Effect of race/ethnicity on participation in HIV vaccine trials and comparison to other trials of biomedical prevention - Wikidata - wikimedia - TriplyDB

Effect of race/ethnicity on participation in HIV vaccine trials and comparison to other trials of biomedical prevention

Effect of race/ethnicity on participation in HIV vaccine trials and comparison to other trials of biomedical prevention

http://www.wikidata.org/entity/Q30206105

about

Sex, age, race and intervention type in clinical studies of HIV cure: a systematic review.Challenges in Recruiting People Who Use Drugs for HIV-Related Biomedical Research: Perspectives from the Field.A successful approach to minimizing attrition in racial/ethnic minority, low-income populations.

P2860

Q34870233-279717EA-7478-4938-BD68-71BCBBE690D7 Q40581397-69ED546D-AABE-4405-87CA-043D7208CFBA Q53378717-3989F529-0746-493D-86D9-591E8C2D6A33

P2860

Effect of race/ethnicity on participation in HIV vaccine trials and comparison to other trials of biomedical prevention

http://www.wikidata.org/entity/Q30206105

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Effect of race/ethnicity on pa ...... rials of biomedical prevention

@ast

Effect of race/ethnicity on pa ...... rials of biomedical prevention

@en

type

label

Effect of race/ethnicity on pa ...... rials of biomedical prevention

@ast

Effect of race/ethnicity on pa ...... rials of biomedical prevention

@en

prefLabel

Effect of race/ethnicity on pa ...... rials of biomedical prevention

@ast

Effect of race/ethnicity on pa ...... rials of biomedical prevention

@en

P1433

Q30206105-D9410CD4-F084-4192-9E83-D447AB353F8E

P1476

Q30206105-23D8B90C-499A-4299-B1CA-04E1BA5A175B

P2093

Q30206105-5693119A-B890-4D1F-AE61-91FDC260721E

Q30206105-ACF8CA5C-5F9C-4A53-A13D-6372758C8253

P2860

Q30206105-032B0D13-9990-4EAE-9B55-A775E2E01D29

Q30206105-05C9DEDF-F5A3-42A4-9ECA-97159F697476

Q30206105-120A04F6-484A-48D3-8DC9-BA907C5F3403

Q30206105-18DB09D9-044B-40EA-8F9D-455B7D82F168

Q30206105-236838F1-3E90-4A49-908F-6D0982F790D9

Q30206105-24BB7EEB-36AF-46A7-9B65-FC7176F0BBD4

Q30206105-28E730D2-5BE3-4974-A4DB-600161970150

Q30206105-2E6E4C7A-ADA2-4498-BFBF-37F7C6A93272

Q30206105-36D4FE7C-5D45-4BCE-AF3B-F1C016C77247

Q30206105-396A4BDE-F55D-4A05-BBE4-28E0A79FDD01

P304

Q30206105-4AF4DFF7-2AC7-4490-807D-C87424D280E8

P31

Q30206105-8DA2E19B-B2AB-4E29-A0E8-C83458D48D4B

P356

Q30206105-D13632E1-DE58-479B-8E7D-B057D4768727

P433

Q30206105-3E71B3BC-28C7-413E-BDFF-95BFD2429E16

P478

Q30206105-4F322C63-EA86-491D-8487-9925A3DD3E3B

P577

Q30206105-41C8B137-F365-44A1-BA25-E86AEB420892

P5875

Q30206105-21910A18-615F-4341-8C6F-93827ABC727C

P698

Q30206105-E0C50898-9EF0-4FFE-9BEC-D9C70034BCCA

P921

Q30206105-4133AD84-ECED-49FE-A246-C17A3C54EB89

P932

Q30206105-21F8B05A-28A0-4338-AC8E-C29FCFF1E696

P356

P1433

Human Vaccines & Immunotherapeutics

P1476

Effect of race/ethnicity on pa ...... rials of biomedical prevention

@en

P2093

Gary Poole

http://www.w3.org/2001/XMLSchema#string

Shayesta Dhalla

http://www.w3.org/2001/XMLSchema#string

P2860

Correlates of HIV acquisition in a cohort of Black men who have sex with men in the United States: HIV prevention trials network (HPTN) 061

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

Preexposure chemoprophylaxis for HIV prevention in men who have sex with men

Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand

Barriers of enrolment in HIV vaccine trials: a review of HIV vaccine preparedness studies.

Motivators of enrolment in HIV vaccine trials: a review of HIV vaccine preparedness studies.

P304

1974-1984

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/HV.28870

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262014872

http://www.w3.org/2001/XMLSchema#string

P698

25424807

http://www.w3.org/2001/XMLSchema#string

P921

prevention of HIV/AIDS

P932

4186048

http://www.w3.org/2001/XMLSchema#string